Pavan Kumar | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Pavan Kumar | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Pavan Kumar , Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, India

Dr. Pavan Kumar is an Assistant Professor at the Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, India. With a Ph.D. from the prestigious Indian Institute of Technology (IIT) Kanpur, Dr. Kumar has made significant contributions to biomedical research, focusing on head and neck cancer detection. His research integrates spectroscopic and imaging devices for non-invasive detection of oral and throat cancers. Dr. Kumar has published 8 journal articles and has contributed to two books. He is well-versed in applying machine learning tools, including PCA, LDA, SVM, and others, to improve cancer diagnosis. His work also involves developing portable devices for in-vivo testing. Dr. Kumar is dedicated to bridging the gap between technology and healthcare, demonstrating excellence in both research and teaching.

Publication Profile:

Orcid

Strengths for the Award:

Dr. Pavan Kumar’s work in the field of head and neck cancer detection using innovative bio-photonics techniques is exemplary. His research focuses on non-invasive diagnostic methods, such as fluorescence spectroscopy, Stokes shift, and diffuse reflectance spectroscopy, which have significant potential in clinical applications for early cancer detection. He has developed portable, handheld devices for in-vivo testing of oral cancers, showcasing his innovation in medical technology. Dr. Kumar’s expertise in machine learning tools like PCA, LDA, and SVM for data classification demonstrates his ability to integrate advanced computational techniques into medical diagnostics. Additionally, his publication record, with 8 journal articles and several book chapters, reflects his dedication to advancing the field. Dr. Kumar has also collaborated with various researchers, further enhancing the depth of his work.

Areas for Improvement:

While Dr. Kumar’s research is highly focused and innovative, expanding his collaborations to include larger multidisciplinary teams or industry partnerships could provide additional avenues for technology transfer and real-world applications. Increasing the scope of his work to include other cancer types or medical conditions could broaden the impact of his research. Furthermore, engaging in more professional memberships and editorial roles could increase his visibility and influence within the global research community.

Education:

Dr. Pavan Kumar completed his Ph.D. in Biomedical Engineering from the Indian Institute of Technology (IIT) Kanpur in 2020. His doctoral research was focused on the development of spectroscopic and imaging techniques for the detection of head and neck cancer. Prior to his Ph.D., he completed a Master’s degree in Biomedical Engineering, gaining a solid foundation in both theoretical and practical aspects of medical technology. His academic journey also includes a postdoctoral position in the Department of Biomedical Engineering at IIT Ropar, where he continued to expand his expertise in the field of bio-photonics and cancer detection. Dr. Kumar’s educational background provided him with the tools to develop innovative methods in cancer diagnosis using fluorescence spectroscopy, Stokes shift, and diffuse reflectance techniques. His education laid the foundation for a career marked by both academic and research excellence.

Experience:

Dr. Pavan Kumar has over five years of experience in academic research, teaching, and development of diagnostic devices. After completing his Ph.D. from IIT Kanpur, Dr. Kumar worked as a postdoctoral fellow at IIT Ropar (January 2020 to January 2021) in the Department of Biomedical Engineering. During this period, he focused on cancer detection using advanced spectroscopic and imaging techniques. Since then, Dr. Kumar has been an active faculty member at the Faculty of Engineering and Technology (FEAT), Datta Meghe Institute of Higher Education and Research (DMIHER), DU, where he teaches medical physics and coordinates project-based learning initiatives. His work combines cutting-edge technology with practical applications, such as in-vivo cancer detection using handheld devices. Dr. Kumar has published extensively in peer-reviewed journals, with his work focused on applying machine learning models to improve diagnostic accuracy. His contributions have significantly advanced the fields of biomedical engineering and bio-photonics.

Research Focus:

Dr. Pavan Kumar’s primary research focus lies in the development of advanced spectroscopic and imaging techniques for the early detection of head and neck cancers. Specifically, he has concentrated on fluorescence spectroscopy, Stokes shift (SS), and diffuse reflectance (DR) as non-invasive tools for diagnosing oral and throat cancers. His work includes the development of handheld, portable devices that use fluorescence for in-vivo testing of oral mucosal lesions. Dr. Kumar’s research also integrates machine learning algorithms, such as Principal Component Analysis (PCA), Linear Discriminant Analysis (LDA), and Support Vector Machines (SVM), to classify different stages of cancer and enhance diagnostic precision. Additionally, his exploration of human saliva as a diagnostic medium for cancer detection demonstrates his commitment to innovative, cost-effective solutions in healthcare. Through his interdisciplinary research, Dr. Kumar is pushing the boundaries of bio-photonics to provide accessible and accurate diagnostic tools for cancer detection.

Publications Top Notes:

  1. Detection of Oral Mucosal Lesions by Fluorescence Spectroscopy and Classification of Cancerous Stages by Support Vector Machine – Lasers in Medical Science (2024) 🔬📊

  2. Human Saliva as a Substitute Diagnostic Medium for the Detection of Oral Lesions Using Stokes Shift Spectroscopy – Asian Pacific Journal of Cancer Prevention (2023) 💧🦷

  3. In-vivo Testing of Oral Mucosal Lesions with an In-house Developed Portable Imaging Device and Comparison with Spectroscopy Results – Journal of Fluorescence (2023) 💡🔍

  4. Detection of Oral Cancer Using Fluorescence Spectroscopy and Classification of Different Stages of Cancer by Multivariate Analysis – ICETEMS Conference (2022) 🦷📉

  5. Fluorescence-Based Handheld Imaging Device for In-vivo Detection of Oral Precancer – Optics InfoBase (2021) 💡🖥️

  6. Porphyrin as a Biomarker for the Detection of COVID-19 Using Fluorescence Spectroscopy and Human Body Fluid Saliva – Applied Research Development (2021) 🦠🧪

  7. Fluorescence-Based Handheld Imaging Device for In-vivo Detection of Oral Precancer – Translational Biophotonics (2021) 💡📱

  8. Detection of Inaccessible Head and Neck Lesions Using Human Saliva and Fluorescence Spectroscopy – Lasers in Medical Science (2021) 👄🔬

  9. Human Tissue and Saliva as Diagnostic Media for Detection of Oral Cancer Using Stokes Shift Spectroscopy – Asian Journal of Physics (2020) 🔬🧪

  10. In Vivo Detection of Oral Precancer Using a Fluorescence-Based, In-House-Fabricated Device – Lasers in Medical Science (2019) 🦷💡

Conclusion:

Dr. Pavan Kumar is undoubtedly a highly deserving candidate for the Research for Best Researcher Award. His contributions to cancer detection, especially in head and neck cancers, using spectroscopy and machine learning, have the potential to revolutionize diagnostic methods. His innovative approach to bio-photonics and commitment to advancing medical technology make him an outstanding researcher in his field. With continued growth in collaboration and outreach, Dr. Kumar’s work has the potential to make a profound impact on global healthcare.

Kewalin Inthanon | Lipid Signaling Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Kewalin Inthanon | Lipid Signaling Biology | Best Researcher Award

Assist. Prof. Dr. Kewalin Inthanon , Thammasat University , Thailand

Dr. Kewalin Inthanon is an Assistant Professor at Thammasat University’s Faculty of Science and Technology in Lampang, Thailand. With a robust academic background, he holds a Ph.D. in Biology from Chiang Mai University and an M.Phil. in Clinical Neuroscience from the University of Cambridge. His expertise is in biotechnology, biochemistry, and the application of natural products and biomaterials to cellular and molecular research. Dr. Inthanon has contributed extensively to the study of cell cultures, oxidative stress, cellular senescence, and the effects of plant extracts, drugs, and biomaterials on cellular functions. His academic career is complemented by numerous research publications and successful research projects focusing on advancing the therapeutic potential of natural compounds and biocompatible materials. As a recognized researcher with notable expertise, he has become an influential figure in the fields of cellular biology and biotechnology.

Publication Profile: 

Orcid

Strengths for the Award

  1. Expertise and Research Focus: Dr. Inthanon has specialized expertise in biochemistry, biotechnology, and the integration of natural products with biomaterials. His research into cytotoxicity, oxidative stress, cellular senescence, and cellular responses to plant extracts, drugs, and biomaterials demonstrates a profound commitment to addressing both fundamental and applied scientific problems. His focus on stem cells, cancer cells, and natural compounds, particularly in the context of human cell cultures, is highly relevant to cutting-edge biotechnology.

  2. Publication Record: Dr. Inthanon’s extensive publication record includes high-impact journal articles in reputable journals like Scientific Reports, Chemistry of Natural Compounds, and Biocatalysis and Agricultural Biotechnology. His papers are well-cited, and he has co-authored several influential studies on the pharmacological and therapeutic properties of plant-derived compounds and biomaterials.

  3. Academic and Research Leadership: As an academic lecturer at Thammasat University and a postdoctoral researcher at Chiang Mai University, Dr. Inthanon demonstrates leadership in guiding the next generation of scientists. His involvement in multiple research projects and the administration of a major phytochemical analysis and bioactivity study on Dillenia indica L. shows his proactive approach to research development.

  4. Innovation and Collaborative Approach: Dr. Inthanon is an excellent collaborator, as seen in his contributions to multi-author publications and his involvement in collaborative projects across different research fields, such as bioengineering, cell culture systems, and plant-derived natural products. This collaborative nature reflects his ability to contribute effectively to both local and international scientific communities.

  5. Peer Review and Recognition: His participation as a peer reviewer for journals such as Food Science & Nutrition and Exploration of BioMat-X further underscores his credibility and recognition within the research community.

Areas for Improvement

  1. Expansion of Interdisciplinary Research: While Dr. Inthanon has done well in integrating natural products with biomaterials and biotechnology, further expansion into interdisciplinary research involving fields such as nanotechnology, synthetic biology, or environmental biotechnology could open up new avenues for innovation.

  2. Increased Public Outreach: Engaging in more public outreach or science communication could help Dr. Inthanon bridge the gap between academic research and broader societal impacts. This could involve more public lectures, writing for popular science outlets, or working with non-academic stakeholders (such as the pharmaceutical industry) to translate research into practical applications.

  3. Development of Commercializable Products: While Dr. Inthanon has demonstrated strong research on natural compounds and biomaterials, focusing on the development of commercializable biotechnological products, such as drugs or health supplements, could further highlight his potential for impactful, real-world applications.

Education:

Dr. Kewalin Inthanon completed his Bachelor of Science (BSc) and Master of Science (MSc) in Biology at Chiang Mai University, Thailand, where he developed a solid foundation in biological sciences. He later pursued an M.Phil. in Clinical Neuroscience at the University of Cambridge, UK, which furthered his understanding of the cellular mechanisms underlying diseases and therapies. Dr. Inthanon earned his Ph.D. in Biology from Chiang Mai University in 2015, specializing in biotechnology and biochemistry, with a focus on human and animal cell culture systems. His diverse educational background has enabled him to combine basic biological research with applied studies in the biomedical and biotechnological fields. Dr. Inthanon’s interdisciplinary education and training make him well-equipped to investigate the molecular and cellular effects of biomaterials, natural products, and therapies, making significant contributions to the field of cell biology and tissue engineering.

Experience:

Dr. Kewalin Inthanon has extensive experience as an academic lecturer at the Department of Biotechnology, Faculty of Science and Technology, Thammasat University, Lampang Campus, Thailand, since 2016. His academic work involves teaching and guiding students in the fields of biotechnology and biochemistry. Prior to his current role, Dr. Inthanon completed a postdoctoral fellowship in biomaterial and tissue engineering at Chiang Mai University from 2015 to 2016. This experience enabled him to specialize in bioengineering, stem cell research, and cellular responses to biomaterial scaffolds. His involvement in various collaborative research projects further honed his skills in experimental design and analysis, leading to numerous peer-reviewed publications. Additionally, Dr. Inthanon has played an essential role in managing and supervising projects focused on the development of natural products and biocompatible materials for therapeutic applications. His expertise in cell culture techniques, biomaterials, and natural products makes him a valuable asset to the research community.

Research Focus:

Dr. Kewalin Inthanon’s research primarily focuses on the intersection of biotechnology, biochemistry, and natural product science. His work explores the effects of plant extracts, drugs, natural compounds, and biomaterials on human cell cultures, including stem cells and cancer cells. He is particularly interested in the cellular responses to oxidative stress, cytotoxicity, cellular senescence, and the modulation of gene expression in the context of disease prevention and treatment. Dr. Inthanon’s research aims to unravel complex signaling pathways and the molecular mechanisms that underlie cellular activities when exposed to various bioactive substances. This research is particularly relevant in the fields of cancer therapy, aging, and regenerative medicine, where the therapeutic potential of natural products can provide novel approaches to disease treatment. Additionally, his work on biomaterials, especially in tissue engineering, emphasizes creating biocompatible scaffolds to support cellular growth and differentiation in medical applications.

Publications Top Notes:

  1. Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential 🧬💪

  2. Cytotoxic Constituents of the Fruits of Garcinia schomburgkiana 🍊💥

  3. Collagen‐cellulose‐poly (l‐lactide) scaffold by electrospinning and plasma‐assisting fabrication for bone tissue engineering applications 🦴🔬

  4. Phytochemical Profiles and Anticancer Effects of Calophyllum inophyllum L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung Cancers 🌿🦠

  5. In vitro assessment of antioxidant and anti-aging properties of ethanol extracts from Amaranthus dubius, Perilla frutescens (L.) britton, and Phyllanthus emblica 🌱⏳

  6. Identification of highly potent α-glucosidase inhibitors from Garcinia schomburgkiana and molecular docking studies 🧪🧠

  7. Sequencerelated amplified polymorphism (SRAP) molecular marker: DNA fingerprinting studying on economic and agricultural earthworms in North of Thailand 🧬🐍

  8. Chemical Constituents of the Stem Bark of Bombax ceiba 🌳🔬

  9. Intrinsic Cellular Responses of Human Wharton’s Jelly Mesenchymal Stem Cells Influenced by O2-Plasma-Modified and Unmodified Surface of Alkaline-Hydrolyzed 2D and 3D PCL Scaffolds 🔬⚙️

  10. Kluai Hom-Thong, biofermented solution, effective microorganism, banana, disease resistance 💡

Conclusion

Dr. Kewalin Inthanon is highly deserving of the Best Researcher Award. His innovative approach to research, combined with his impressive publication record, leadership in academia, and interdisciplinary expertise, make him an exceptional candidate. His focus on biotechnology, biochemistry, and natural products holds significant potential for advancing therapeutic and scientific advancements, particularly in the areas of aging, cancer, and stem cell research.

Dominique Heymann | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Dominique Heymann | Cancer Cell Biology | Best Researcher Award

Prof. Dr. Dominique Heymann , Nantes Université, CNRS, Institut de Cancérologie de l”Ouest , France

Professor Dominique Heymann is a highly esteemed academic and clinician, specializing in histology, embryology, and oncology. He is a Professor at Nantes University, France, and a Hospital Practitioner at the ICO Cancer Centre. With a wealth of experience in bone oncology and cancer research, he is also an Honorary Professor at the University of Sheffield, UK. His expertise spans from cell biology to immunology and biochemistry, and he is dedicated to advancing cancer research, particularly in the field of bone tumors and osteosarcoma. With numerous publications to his name and contributions to the global scientific community, Professor Heymann is recognized for his groundbreaking work in cell signaling and tumor progression. He is a valued researcher in the oncology community, with a strong focus on developing innovative therapies for cancer treatment.

Publication Profile:

Google Scholar

Strengths for the Award:

Professor Dominique Heymann is a distinguished figure in the field of oncology, particularly bone oncology, with a strong focus on the molecular mechanisms of bone tumors like osteosarcoma. His academic and clinical roles at the University of Nantes and the ICO Cancer Centre underscore his leadership in research and patient care. He has contributed significantly to understanding tumor biology, bone remodeling, and regenerative medicine, making him a highly respected expert in these fields. His research addresses crucial topics such as circulating tumor cells, targeted therapies, and the development of new anticancer agents, all of which are of immense value to advancing cancer treatment. With multiple publications in prestigious journals, including studies on novel therapies and molecular pathways in cancer progression, Professor Heymann has demonstrated exceptional scientific rigor. His global collaborations and recognition further establish him as a leading researcher in cancer biology and oncology.

Areas for Improvements:

Despite his numerous contributions, there are a few areas where Professor Heymann’s research could evolve. While he has made notable strides in cancer treatment and bone oncology, expanding research into more personalized medicine approaches and exploring the integration of AI and machine learning in predictive oncology could enhance the applicability of his findings. Furthermore, increasing collaborative efforts with international interdisciplinary teams could yield broader insights, especially in rare cancers and metastasis research. Developing a more extensive outreach to clinical trials and collaborations in broader regions may also allow for faster translation of his research into practice.

Education:

Professor Heymann began his academic journey at Paris VII University, where he earned a Master’s degree in Cell Biology in 1991. His PhD in Cell Biology and Immunology was completed at Nantes University in 1995, a pivotal moment in his career. Further expanding his knowledge, he pursued research management abilities and a deeper focus on Biochemistry and Cell Biology at Nantes University in 1998. He also received specialized certification in Histology from Nantes University in 1999 and later completed the required authorizations for animal experimentation in 2003 and 2016. Throughout his academic career, Professor Heymann has continually updated his qualifications, ensuring his expertise remains at the cutting edge of medical and biological sciences. His academic foundation has underpinned his significant contributions to cancer research, with a strong emphasis on bone oncology and regenerative medicine.

Experience:

Professor Dominique Heymann has an extensive and diverse career spanning several decades in both academic and clinical settings. Currently, he serves as a Professor of Histology/Embryology at Nantes University and as a Hospital Practitioner at the ICO Cancer Centre, where he is instrumental in patient care and research. His professional trajectory includes significant roles in oncology, particularly focused on bone tumors, osteosarcoma, and regenerative medicine. As an Honorary Professor at the University of Sheffield, he extends his influence beyond France, fostering international collaboration in cancer research. Professor Heymann has been a prominent figure in multiple research projects, having managed and contributed to groundbreaking studies. His expertise in cancer biology, combined with his academic roles, has allowed him to mentor students and researchers, shaping the next generation of scientists. His dual role in academia and clinical practice makes him a leading figure in both spheres.

Awards and Honors:

Professor Dominique Heymann’s career is adorned with numerous accolades and honors. As a tenured professor at the University of Nantes, he has received recognition for his contributions to histology, embryology, and oncology. He was appointed as an Honorary Professor in Bone Oncology at the University of Sheffield, UK, an esteemed acknowledgment of his expertise in the field. His work in cancer research, particularly related to bone tumors, has earned him international recognition, and his published studies continue to be highly regarded in scientific journals. Additionally, Professor Heymann has contributed significantly to the understanding of osteosarcoma and bone regeneration, which has earned him awards from academic and clinical societies. His continuous impact in advancing the field through groundbreaking research, leadership in clinical oncology, and educational contributions has made him a highly respected figure in the medical and scientific communities.

Research Focus:

Professor Dominique Heymann’s research is focused on cancer, particularly bone tumors such as osteosarcoma, and the molecular mechanisms involved in bone regeneration. His work primarily investigates the signaling pathways that control bone remodeling, the interactions between tumor cells and the microenvironment, and the role of immune responses in bone diseases. One of his key research interests is the development of targeted therapies to combat cancer progression, with a special emphasis on novel anticancer agents, including glycosaminoglycan-mimetic compounds derived from marine bacterial exopolysaccharides. In addition, Professor Heymann is dedicated to studying the role of circulating tumor cells as predictive markers for drug resistance and tumor progression. His expertise also includes stem cell therapies, autophagy in osteoblasts, and the potential for therapeutic applications in bone repair and regeneration. His research aims to improve patient outcomes through innovative approaches in cancer treatment and bone health.

Publications Top Notes:

  • Heymann D, Muñoz-Garcia J, Babuty A, et al. A new promising anticancer agent: a glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharide. Int J Biol Macromol. (in press) 🧬

  • Jacquot P, Muñoz-Garcia J, Léger A, et al. A multispecific checkpoint inhibitor Nanofitin with a fast tumor accumulation property and antitumor activity in immune competent mice. Biomolecules. (in press) 🔬

  • Yadav P, Heymann D, Prasad RN. Circulating tumor cells: a predictive marker for drug resistance and tumor progression. Front Oncol. (in press) 🔬

  • Muñoz-Garcia J, et al. Interleukin-34 orchestrates bone formation through its binding to Bone Morphogenic Proteins. Theranostics. 2025; 15(7):3185-3202. 🦴

  • Young RJ, et al. CIRCUS: CIRCUlating tumor cells in soft tissue Sarcoma – a short report. Cancer Drug Resist. 2022; 4:51. 💉

  • Oliver L, et al. Transcriptional landscape of the interaction of human mesenchymal stem cells with glioblastoma in bioprinted co-cultures. Stem Cell Res Ther. 2024; 15(1):424. 🧫

  • Cordova LA, et al. Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care? Osteoporos Int. 2024; 35(9):1677-1678. 🦷

  • Childs A, et al. A prospective observational cohort study for newly diagnosed patients in the UK: ICONIC study initial results. Cancers (Basel). 2024; 16(13):2351. 📊

  • Rey V, et al. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma. EBioMedicine. 2024; 102:105090. 🧬

  • Jubelin C, et al. Identification of MCM4 and PKRDC as new regulators of osteosarcoma cell dormancy based on 3D cultures. BBA Mol Cell Res. 2024; 1871:119660. 🧪

Conclusion:

Professor Dominique Heymann’s expertise in oncology, histology, and embryology positions him as an outstanding candidate for the Research for Best Researcher Award. His achievements in cancer research, particularly in bone tumors, and his contributions to advancing the understanding of tumor biology make him an exemplary figure. While there are areas to expand in terms of interdisciplinary collaborations and technological integration, his exceptional body of work and his dedication to both academic excellence and clinical practice make him a deserving candidate for this prestigious award.

Jinlin Song | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Jinlin Song | Tissue Engineering Regeneration | Best Researcher Award

Prof. Dr. Jinlin Song , The Affiliated Stomatological Hospital of Chongqing Medical University , China

Prof. Jinlin Song is the current Dean of the Affiliated Stomatological Hospital of Chongqing Medical University, China. With a distinguished career in the field of dentistry, he holds a BS, MS, and Ph.D. from West China Medical University. Prof. Song has extensive experience in orthodontics and tissue engineering, particularly focused on periodontal regeneration in diabetic patients. Throughout his career, he has held prominent positions, including Vice Dean and Director of the Orthodontics Department at his institution. He is a well-regarded member of multiple prestigious professional organizations, including the World Federation of Orthodontists and the International College of Dentists. Prof. Song has published 264 scientific papers, holds 32 patents, and has contributed significantly to advancements in maxillofacial tissue engineering and regenerative therapies.

Publication Profile: 

Scopus

Strengths for the Award:

Prof. Jinlin Song is an exceptional candidate for the Best Researcher Award due to his groundbreaking contributions to the field of maxillofacial tissue engineering and orthodontics. His work in periodontal tissue regeneration, particularly in diabetic patients, has been pivotal in advancing clinical therapies and addressing long-standing challenges. Prof. Song has a remarkable publication record, with 264 papers in SCI journals, and has been recognized with numerous prestigious awards, including the 2023 National Science and Technology Progress Award. Additionally, his innovative approach to bone repair and tissue regeneration using novel scaffolds and therapeutic techniques exemplifies his leadership in dental and medical research. His 32 published patents further highlight his ability to translate research into real-world solutions.

Areas for Improvement:

Although Prof. Song’s research portfolio is impressive, expanding his focus into more interdisciplinary collaborations—especially in the realms of digital dentistry and AI-based diagnostic tools—could enhance the broader impact of his work. Further collaboration with industry leaders in the development of dental technologies might also increase the practical application of his innovations.

Education:

Prof. Jinlin Song pursued his academic journey at West China Medical University, where he completed his BS in Stomatology (1991-1996). He then continued his studies at the same university, earning both his Master’s and Ph.D. in Stomatology (1996-2001). Afterward, Prof. Song advanced his research expertise as a postdoctoral fellow at the Sichuan University Post-Doctoral Research Station (2001-2003). These academic credentials laid the foundation for his subsequent groundbreaking work in orthodontics and maxillofacial tissue engineering. Prof. Song’s continuous pursuit of innovation and research excellence has made him an influential figure in his field, furthering the development of regenerative therapies for periodontal tissue and orthodontic treatments.

Experience:

Prof. Jinlin Song has over two decades of experience in dental research and education. He began his career at the Affiliated Stomatological Hospital of Chongqing Medical University, where he was appointed Vice Director of the Orthodontics Department (2003-2004) and later became the Director of the department (2005-2013). He then took on the role of Vice Dean at the institution from 2013 to 2022. In March 2023, he was appointed as Dean, overseeing the academic and research directions of the hospital. Prof. Song’s leadership is evident in his involvement in various national and international projects, awards, and collaborations in the areas of orthodontics, tissue engineering, and regenerative medicine. His extensive publication record and patent portfolio demonstrate his pivotal role in advancing dental science and clinical practices, particularly in periodontal tissue regeneration and orthodontic treatment.

Research Focus :

Prof. Jinlin Song’s primary research focus lies in maxillofacial tissue engineering, particularly in periodontal tissue regeneration and orthodontic treatment innovations. He has made significant strides in addressing the challenges of periodontal tissue regeneration, especially in diabetic patients, by exploring combined therapeutic approaches like low-intensity pulsed ultrasound and metformin. His team has developed innovative scaffolds, including filamentous proteins and decellular matrix scaffolds, which have been shown to effectively improve clinical outcomes in bone repair and tissue regeneration. Prof. Song is also dedicated to studying the interactions between tissue regeneration and biological processes such as inflammation and macrophage energy metabolism. His work has garnered numerous awards, including national and provincial science and technology prizes. The long-term impact of his research aims to bridge the gap in clinical therapies for periodontal regeneration and other oral health challenges.

Publications Top Notes:

  • Nanoparticles Encapsulating Antigenic Peptides Induce Tolerogenic Dendritic Cells in Situ for Treating Systemic Lupus Erythematosus 🦠

  • Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism ⚙️

  • Heavy Mechanical Force Decelerates Orthodontic Tooth Movement via Piezo1-Induced Mitochondrial Calcium Down-Regulation 🔧

  • Effectiveness Evaluation of a Serious Game for Dental Lost Wax Casting Training 🎮

  • Neutrophil Airfreighter Efficiently Delivers siRNA-Loaded Nanocomplex to Mononuclear Phagocytes for Inhibition of mtDNA-Induced Inflammation 📦

  • Convertible Hydrogel Injection Sequentially Regulates Diabetic Periodontitis 💉

  • Scale for Measuring Critical Thinking Ability for Dental Residents: A Development and Validation Study 📊

Conclusion:

Prof. Jinlin Song’s exceptional academic and research accomplishments make him a highly deserving candidate for the Best Researcher Award. His work has not only contributed to academic knowledge but has also led to tangible improvements in clinical practice, making a profound impact on oral health care, particularly in tissue regeneration and orthodontics. Prof. Song’s career serves as an inspiration for future researchers in the field.

 

 

 

Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Gary Chan | Host-Pathogen Interactions | Best Researcher Award

Dr. Gary Chan , SUNY Upstate Medical University , United States

Dr. Gary Ching-Tao Chan is a distinguished professor in the Department of Microbiology and Immunology at SUNY Upstate Medical University, Syracuse, NY. He completed his Ph.D. in Immunology at the University of Alberta, Canada, under the supervision of Dr. Larry J. Guilbert. Dr. Chan’s research expertise lies in viral immunology, particularly in human cytomegalovirus (HCMV) and dengue virus (DENV). He has a robust research portfolio with numerous contributions to the field, focusing on viral-host interactions and immune modulation. His work has led to groundbreaking discoveries in HCMV pathogenesis, including viral modulation of autophagy and cell signaling pathways. Dr. Chan has held academic appointments at prestigious institutions, including Louisiana State University Health Science Center, where he contributed significantly to advancing viral immunology. His commitment to research excellence is reflected in his impactful publications and active grant support.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Prolific Research Contributions: Dr. Gary Chan has made significant contributions to the field of microbiology, particularly in the understanding of human cytomegalovirus (HCMV) and its complex interactions with the immune system. His work has been consistently published in top-tier peer-reviewed journals such as Journal of Virology, Antiviral Research, and mBio, highlighting his influence in virology.

  2. Innovative and High-Impact Research: Dr. Chan’s research addresses fundamental aspects of viral pathogenesis, focusing on viral-host interactions, immune modulation, and viral replication. His innovative exploration into the molecular mechanisms of HCMV, such as the modulation of mTORC1 and the role of host transcription factors like HSF1, is groundbreaking and provides valuable insights for potential therapeutic strategies. His studies have also demonstrated significant contributions in understanding how viruses, including HCMV and Dengue virus, alter host cell signaling pathways, making his work crucial in antiviral research.

  3. Successful Grant Support: Dr. Chan has received substantial funding for his research, including multiple NIH R01 grants. His current projects, such as targeting the nuclear HSF1 for anti-HCMV strategies, are promising avenues for the development of novel antiviral therapies, further solidifying his standing as a leading researcher in his field.

  4. Recognition by Peers and Journals: His work has been widely recognized by peers in the field, as evidenced by the Journal of Virology Editor’s Pick in 2024 and the Journal of Virology Spotlight Article of Significant Interest in 2020. These accolades underline the impact and relevance of his research.

  5. Mentorship and Academic Leadership: As a Professor at SUNY Upstate Medical University, Dr. Chan contributes significantly to the academic and professional development of students and colleagues alike. His role in shaping the next generation of researchers, combined with his leadership in the field, highlights his commitment to advancing science.

Areas for Improvement:

  1. Broader Impact Across Other Virus Families: While Dr. Chan’s research on HCMV is groundbreaking, exploring the broader spectrum of viral infections, including RNA viruses like SARS-CoV-2, could expand his impact across viral disease research. By diversifying his focus, he could address other significant public health threats, further enhancing the breadth of his research.

  2. Increased Interdisciplinary Collaboration: Although Dr. Chan has successfully collaborated with various experts in the field of virology, fostering interdisciplinary collaborations with researchers from fields such as bioinformatics, computational biology, and structural biology could accelerate the development of novel antiviral therapies and improve the understanding of viral mechanisms.

  3. Public Engagement and Communication: Dr. Chan’s impactful research is highly technical, and while it has contributed to the scientific community, increased efforts in communicating his findings to the broader public could help in promoting awareness of viral infections and their treatment. Public engagement through media, outreach programs, or collaborative projects with health organizations could amplify his work’s societal impact.

Education:

Dr. Gary Chan earned his Ph.D. in Immunology from the University of Alberta, Edmonton, Canada, from 1999 to 2005. His doctoral research focused on “Human cytomegalovirus-induced trophoblast apoptosis,” under the mentorship of Dr. Larry J. Guilbert in the Department of Medical Microbiology and Immunology. Following his Ph.D., Dr. Chan pursued postdoctoral training at Louisiana State University Health Science Center (2006–2011) in the Department of Microbiology and Immunology. Under the guidance of Dr. Andrew Yurochko, his postdoctoral research expanded his expertise in virology and immune modulation. Dr. Chan’s extensive academic background, coupled with his training in cutting-edge viral immunology, has laid the foundation for his pioneering work on viral-host interactions, particularly with human cytomegalovirus (HCMV), contributing to novel therapeutic strategies.

Experience:

Dr. Gary Chan is a Professor at the Department of Microbiology and Immunology at SUNY Upstate Medical University, a role he has held since 2023. Prior to this, he was an Associate Professor at the same department from 2018 to 2023. Dr. Chan has a wealth of experience in virology and immunology, with a focus on human cytomegalovirus (HCMV) and dengue virus (DENV). He has been instrumental in advancing research on the molecular mechanisms of viral infections and their impact on the host immune system. Dr. Chan’s academic journey includes several years of postdoctoral training at Louisiana State University, where he contributed to significant findings in viral replication and immune responses. With a comprehensive background in molecular virology, cell biology, and immunology, Dr. Chan is recognized for his expertise in viral pathogenesis and therapeutic research.

Awards and Honors:

Dr. Gary Chan has received numerous prestigious awards and recognitions for his research excellence. In 2024, his publication, Human cytomegalovirus modulates mTORC1 to redirect protein translation within quiescently infected monocytes, was selected as an Editor’s Pick by the Journal of Virology. Additionally, his article on HCMV-induced autophagy preventing necroptosis of infected monocytes was featured as a Spotlight Article of Significant Interest in 2020. His innovative research has earned him continuous recognition within the virology community, including numerous peer-reviewed publications. Dr. Chan’s research contributions have also attracted substantial NIH grant support, including an R01 from the NIAID, to explore novel anti-HCMV strategies targeting nuclear HSF1. His scholarly achievements, including the successful funding of multi-year research projects, underscore his dedication to advancing our understanding of viral diseases and their immune modulation.

Research Focus:

Dr. Gary Chan’s research primarily focuses on viral immunology, specifically human cytomegalovirus (HCMV) and dengue virus (DENV). His work explores how these viruses manipulate host cellular processes, such as signaling pathways and immune responses, to promote viral replication and persistence. One of his major research areas is investigating the interactions between HCMV and monocytes, particularly how the virus modulates autophagy and apoptosis to avoid immune detection and promote its survival. Additionally, Dr. Chan’s research delves into the role of host transcription factors, such as HSF1, in regulating viral replication. His innovative work also involves creating bioswitches through protein and DNA engineering to combat HCMV. Through these projects, Dr. Chan aims to identify novel therapeutic targets to limit viral infections and improve antiviral strategies. His work is pivotal in advancing the understanding of how viral infections impact the host immune system and contribute to disease pathogenesis.

Publications Top Notes:

  1. Targeting HSF1 prevents HCMV replication 🦠

  2. DENV infection induces differential immunotranscriptomic profiles 🦟

  3. B cell receptor enhancement of dengue virus infection 🧬

  4. Virion-associated US28 modulates Akt activity in monocytes 💉

  5. The harms of promoting the leak lab hypothesis for SARS-CoV-2 🧫

  6. HCMV modulates mTORC1 in infected monocytes 💪

  7. Virology – The path forward 🔬

  8. Inhibition of SIRT2 promotes HCMV-infected monocyte death ⚔️

  9. Virology under the Microscope – A call for rational discourse 📚

  10. Modulation of host cell signaling in HCMV latency 🧪

Conclusion:

Dr. Gary Ching-Tao Chan is highly deserving of the Best Researcher Award due to his outstanding contributions to the field of virology, particularly in the area of human cytomegalovirus and its interaction with the immune system. His innovative research has shaped the understanding of viral pathogenesis, leading to potential therapeutic breakthroughs. With significant funding, prestigious recognition, and a strong academic presence, Dr. Chan continues to push the boundaries of scientific knowledge. While there are opportunities for expansion into other viral research areas and greater public outreach, his accomplishments make him a leading figure in microbiology and an excellent candidate for this award.

Doaa Esmaeil | Cancer treatment | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Doaa Esmaeil | Cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Doaa Esmaeil , Mansoura university , Egypt

Dr. Doaa Abd Elmoneim Mohamed Esmaeil is an Associate Professor of Oral Pathology at Mansoura University, Egypt. She is a dedicated researcher focused on oral diseases, particularly in understanding their pathogenesis, molecular biology, and carcinogenesis. With a strong background in oral pathology, she has contributed to numerous studies and publications that explore various aspects of oral health, including cancer research and therapeutic strategies. Dr. Esmaeil’s research includes innovative work on the effects of different agents and treatments in combating oral diseases. Her extensive academic contributions have established her as a prominent figure in the field of oral pathology, both in Egypt and internationally. She is committed to advancing the understanding of oral diseases, particularly those linked to cancer, and plays an active role in advancing the knowledge of oral health practices.

Publication Profile:

Orcid

Strengths for the Award:

  1. Academic Excellence: Dr. Doaa Esmaeil is an Associate Professor in the Oral Pathology Department at Mansoura University, Egypt, with a strong academic background and expertise in oral diseases, particularly oral carcinogenesis and molecular biology. Her contributions to the scientific community through both teaching and research have made her a significant figure in the field.

  2. Research Contributions: Dr. Esmaeil has made notable contributions to oral pathology through her innovative research on molecular mechanisms in oral diseases, focusing on cancer pathogenesis, therapeutic agents, and disease prevention. Her research projects, such as exploring the efficacy of phytomedicines against chemotherapy-induced toxicity, demonstrate her commitment to improving therapeutic outcomes.

  3. International Recognition: She has published several papers in high-impact journals such as the European Journal of Dentistry, Saudi Dental Journal, and the Egyptian Dental Journal, showcasing her widespread impact in the field of oral pathology.

  4. Ongoing Contributions to the Field: Dr. Esmaeil’s research is forward-thinking, addressing cutting-edge topics like stem cells in oral cancer therapy, the role of molecular markers in oral diseases, and enhancing chemotherapeutic efficacy against head and neck cancers.

Areas for Improvement:

  1. Citation Impact: While Dr. Esmaeil has been an active researcher with publications in reputed journals, her citation index of 3, while a good start, could benefit from increased visibility and collaborations with larger research networks to elevate her work’s recognition and citation in the broader academic community.

  2. Industry Collaborations: Although Dr. Esmaeil’s academic and research work is notable, there appears to be limited documented collaboration with industry projects or patents. Strengthening connections with industry could help translate her research into practical applications, potentially enhancing the impact of her work.

  3. Multidisciplinary Collaboration: While Dr. Esmaeil has collaborated with researchers within the field of oral pathology, expanding these collaborations into multidisciplinary domains could provide a more comprehensive approach to her research and open new avenues for funding and innovation.

Education:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil earned her Bachelor’s degree in Dental Medicine from Mansoura University, Egypt. She then pursued her Master’s and Ph.D. degrees in Oral Pathology, also from Mansoura University, where she developed a keen interest in the molecular mechanisms of oral diseases. Her academic journey has been enriched by her work on various research projects exploring oral carcinogenesis, molecular biology, and the development of therapeutic strategies for oral cancers. Dr. Esmaeil’s dedication to research and her extensive educational background have established her as an expert in oral pathology. She has participated in numerous international and national conferences, strengthening her expertise in both academic and clinical settings. Her education and commitment to continuous learning have shaped her approach to understanding and treating oral diseases, and she remains an influential educator and researcher at Mansoura University.

Experience:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil has over a decade of experience in teaching and researching in the field of oral pathology. As an Associate Professor in the Oral Pathology Department at Mansoura University, she has played a pivotal role in educating undergraduate and postgraduate students in both theoretical and practical aspects of oral pathology. Her experience extends to leading numerous research projects in oral diseases, with a special focus on oral cancer, its molecular mechanisms, and therapeutic approaches. Dr. Esmaeil’s work on tissue biomarkers, cancer stem cells, and chemotherapeutic agents has been recognized internationally. Additionally, her role as a reviewer for several scientific journals has solidified her standing as a respected authority in oral pathology. Her collaborative projects with other universities and institutions, both local and international, have further enhanced her research expertise. Dr. Esmaeil’s passion for education and research continues to shape the future of oral pathology.

Research Focus:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil’s research primarily focuses on the molecular pathogenesis of oral diseases, with a particular emphasis on oral cancer. Her work explores the complex mechanisms underlying carcinogenesis in the oral cavity, particularly focusing on the molecular markers, cell lines, and signaling pathways involved in cancer progression. Dr. Esmaeil is also interested in developing innovative therapeutic strategies for oral diseases, with research exploring the efficacy of various agents, including phytomedicines and synthetic compounds, against oral cancer and other related disorders. Her ongoing research examines the effectiveness of combining traditional treatments with new molecular-targeted therapies to improve patient outcomes. Additionally, she has investigated the role of cancer stem cells in therapy resistance and the development of new treatment modalities. Dr. Esmaeil’s research contributes to the broader understanding of oral diseases, aiming to improve both prevention and treatment options for conditions like oral squamous cell carcinoma.

Publication Top Notes:

  • The Impact of Silver Diamine Fluoride and Potassium Iodide Treatment on Microtensile Bonds Strength of Composite Restoration for Carious Dentin in Primary and Permanent Teeth and Its Potential Color Changes: An in Vitro Study 📄🦷

  • Antitumoral properties of the pomegranate peel and blueberry extracts against tongue carcinoma (in vitro study) 🍊🍇🦷

  • Oral squamous cell carcinoma Immunohistochemical Expression of PD L1 in Oral Epithelial Dysplasia 🦷🔬

  • Stem Cell Marker as A Factor for The Different Biological Behavior of Ameloblastoma and Odontogenic Keratocyst 🧬🦷

  • Diagnostic Value of Nuclear Receptor Subfamily 4 Group A Member 3 in Salivary Gland Carcinomas 🔬🦷

  • The controversial role of MDM2, MCM3 and Bcl-X in Ameloblastoma and Ameloblastic Carcinoma: An update 🧬🦷

  • Pomegranate molasses and red grape vinegar: can they alleviate dysplastic changes in chemically induced oral squamous cell carcinoma in hamsters? 🍑🍇🦷

  • Tumor stroma ratio as a parameter for prognosis and clinicopathological behavior of oral squamous cell carcinoma: A retrospective cohort study 📊🦷

  • Emerging therapeutic modality enhancing the efficiency of chemotherapeutic agents against head and neck squamous cell carcinoma cell lines 💊🦷

  • Angiogenesis and mast cells as predictive factors in behavior of Odontogenic cysts 🌱🦷

Conclusion:

Dr. Doaa Abd Elmoneim Mohamed Esmaeil is highly deserving of the Best Researcher Award. Her academic excellence, profound contributions to oral pathology, and commitment to advancing the understanding of oral diseases and cancer pathogenesis make her a strong candidate. By focusing on broadening her citation impact and enhancing her industry collaborations, Dr. Esmaeil has the potential to elevate her career to even greater heights. Her continued research and dedication to the scientific community position her as an influential researcher in the field of oral pathology, contributing not only to academia but also to real-world applications in oral healthcare.

Ramamurthy Chitteti | Mitochondria Metabolism |

Published on by Cell Biologist

Dr. Ramamurthy Chitteti | Mitochondria Metabolism | Best Researcher Award

Dr. Ramamurthy Chitteti , University of California San diego , United States

Dr. Ramamurthy Chitteti is a highly accomplished biochemist and molecular biologist with extensive experience in virology, SARS-CoV-2 research, and mitochondrial biology. He holds a PhD in Biochemistry and Molecular Biology from Pondicherry University, India, and has received post-doctoral training at prestigious institutions such as the University of Cincinnati, IIT Delhi, University of Rochester, and UC San Diego. Currently, Dr. Chitteti serves as a Project Scientist at UC San Diego, contributing to cutting-edge research in vascular diseases related to tobacco products. He has mentored numerous students and researchers, participated in multiple scientific societies, and is a respected reviewer for various scientific journals. With over 23 published papers and an H-index of 14, his contributions are widely recognized in the scientific community.

Publication Profile: 

Scopus

Strengths for the Award:

Dr. Ramamurthy Chitteti possesses a wealth of knowledge and a strong research background in biochemistry, molecular biology, virology, and mitochondrial biology. His extensive educational and research experience, including his PhD from Pondicherry University and post-doctoral training at prestigious institutions, exemplifies his dedication to scientific excellence. Notably, Dr. Chitteti has contributed to over 23 peer-reviewed publications with a significant impact, as evidenced by his H-index of 14 and over 1200 citations. His ability to mentor undergraduate and graduate students, and his recognition through awards like the Junior Scientist Award in Pharmacology and the National Postdoctoral Fellowship Award, further highlight his leadership within the scientific community. Additionally, his collaborative efforts on SARS-CoV-2 research and other disease-related studies show his adaptability and capacity to contribute to pressing global health issues.

Areas for Improvement:

While Dr. Chitteti has established an impressive portfolio of publications and awards, one potential area for improvement could be the expansion of interdisciplinary collaborations with fields outside molecular biology, such as clinical or pharmacological research. This could lead to broader application of his findings, particularly in translational medicine. Increasing his visibility in high-profile international journals and conferences could also help elevate his research to new levels.

Education:

Dr. Ramamurthy Chitteti’s academic journey began with a B.Sc. in Botany, Zoology, and Chemistry, followed by an M.Sc. in Biotechnology. He pursued a Ph.D. in Biochemistry and Molecular Biology at Pondicherry University, where he explored various aspects of cellular and molecular biology. His research during this time was fundamental in shaping his later contributions to the field of virology and molecular biology. Further honing his expertise, he completed post-doctoral research at several esteemed institutions, including the University of Cincinnati, Indian Institute of Technology (IIT) Delhi, University of Rochester, and the University of California, San Diego. His diverse educational background, coupled with international training, has made him an expert in the molecular mechanisms of diseases and a mentor for emerging scientists in the field.

Experience:

Dr. Ramamurthy Chitteti has over 14 years of research experience, including his Ph.D. work. Currently, he is a Project Scientist at the University of California, San Diego, where he investigates the role of exosomes in vascular diseases linked to emerging tobacco products. His previous experience as a Post-Doctoral Researcher at UCSD and the VA Healthcare System included leading studies on cellular responses to stress and disease, including research related to SARS-CoV-2. Dr. Chitteti has a strong track record of securing research funding, with projects funded by the NIH, Veterans Affairs, and other government agencies. He also actively mentors undergraduate and graduate students in the lab, helping them develop critical research skills. With his multifaceted experience in molecular biology, virology, and disease mechanisms, Dr. Chitteti continues to push boundaries in his research on cell stress, mitochondrial function, and exosome biology.

Awards and Honors:

Dr. Ramamurthy Chitteti has received several prestigious awards and honors throughout his career. In 2022, he was honored with the Junior Scientist Award in Pharmacology at the Society of Association of Scientists of Indian Origin in America (ASIOA) annual meetings. His exceptional contributions to research were also recognized with the National Postdoctoral Fellowship Award from the Department of Science and Technology, Government of India, in 2017. Additionally, Dr. Chitteti has been awarded multiple fellowships for his postdoctoral research, showcasing his excellence in scientific discovery. As a respected member of the Association of Scientists of Indian Origin in America (ASIOA), he continues to be an influential figure in scientific communities both in the U.S. and internationally. His continuous pursuit of excellence in scientific research makes him a standout researcher in his field.

Research Focus:

Dr. Ramamurthy Chitteti’s research primarily focuses on the molecular mechanisms underlying diseases such as cancer, viral infections, and vascular diseases. His current work at UC San Diego delves into the role of exosomes in mediating the effects of emerging tobacco products on vascular health, with implications for understanding cardiovascular diseases. Additionally, he is actively exploring the molecular aspects of mitochondria, including their involvement in cell stress and disease pathogenesis. Dr. Chitteti has also contributed significantly to SARS-CoV-2 research, studying how meditation-induced factors can influence COVID-19 outcomes. His broad expertise in virology, cellular biology, and mitochondrial dysfunction positions him at the forefront of molecular disease research. Through his work, Dr. Chitteti aims to develop novel therapeutic strategies, focusing on leveraging molecular biology to enhance disease treatment and prevention.

Publications Top Notes:

  1. Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease 🧘‍♂️💉

  2. Contrasting roles for G-quadruplexes in regulating human Bcl-2 and virus homologues KSHV Ks-Bcl-2 and EBV BHRF1 🧬🦠

  3. KLa(0.95-x) GdxF4:Eu3+ hexagonal phase nanoparticles as luminescent probes for in vitro Hug-7 cancer cell imaging 💡🧫

  4. Cancer Microbiome: Opportunities and Challenges 🦠💡

  5. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth 🧬🧫

  6. Synthesis, spectral characterization, and antitumor activity of phenothiazine derivatives 🧪🔬

  7. Solanum torvum fruit aqueous extract attenuates cadmium nitrate-induced liver and kidney damage 🍇⚖️

  8. The extracellular synthesis of gold and silver nanoparticles and their free radical scavenging and antibacterial properties 💰🔬

  9. Green synthesis of selenium nanoparticles using fenugreek seed extract and its cytotoxicity on cancer cells 🌱💀

  10. E-cigarette-induced changes in cell stress and mitochondrial function 🛑🧬

Conclusion:

Dr. Ramamurthy Chitteti’s exceptional qualifications, including his substantial research experience, impressive publication record, and contributions to the scientific community, make him a deserving candidate for the Research for Best Researcher Award. His ongoing work in molecular aspects of disease mechanisms, exosomes, and tobacco-related vascular health, alongside his commitment to student mentoring and peer review, showcases his strength as both a scientist and an educator. With further engagement in collaborative research and international exposure, Dr. Chitteti has the potential to make even more significant impacts in his field.

Weiqing Zheng | Developmental Cell Biology | Excellence in Research Award

Published on by Cell Biologist

Dr. Weiqing Zheng | Developmental Cell Biology | Excellence in Research Award

Dr. Weiqing Zheng , Hainan Medical University , China

Dr. Weiqing Zheng is an Associate Professor at Hainan Medical University, China. He obtained his doctoral degree from Obihiro University of Agriculture and Veterinary Medicine. He has dedicated over 14 years to research at the Nanchang Centre for Disease Control and Prevention, primarily focusing on the prevention and control of ticks and tick-borne diseases. Since February 2023, he has joined Hainan Medical University, where his work centers on tick-microbe interactions and their impact on tick growth and development. Zheng is widely known for his studies on Coxiella symbionts in ticks, contributing to understanding tick ecology and disease transmission. He has authored 11 journal papers and published two books. His research has been recognized with several citations, and his work continues to shape the understanding of tick biology and its implications for public health.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Weiqing Zheng’s research contributions are highly impactful in the field of tick biology and vector-borne diseases. His work on tick-microbe interactions, especially the role of the endosymbiont Coxiella in regulating tick growth and development, is groundbreaking and has the potential to influence both basic science and public health. His systematic exploration of tick distribution patterns in China, including the Poyang Lake region and Hainan province, adds substantial value to the field of epidemiology. Additionally, Dr. Zheng’s contribution to tick-borne disease research, as well as his ongoing projects and publications, demonstrate his commitment to advancing our understanding of tick biology and its implications for disease transmission.

His high citation index, with 2,866 Research Interest Score, 307 citations, and an h-index of 30, further attests to the impact and relevance of his research. Furthermore, his involvement in editorial appointments, collaborations, and industry consultancy indicates his leadership role in the research community.

Areas for Improvements:

While Dr. Zheng’s research and academic output are impressive, a stronger emphasis on collaborative projects with international research institutions could further expand the global impact of his work. Engaging in broader outreach, such as public health initiatives and awareness programs, could also help translate his findings into actionable measures for tick-borne disease prevention. Additionally, as two of his books are still in publication, the availability of finalized publications could strengthen his overall academic portfolio.

Experience:

Dr. Weiqing Zheng’s extensive career spans over 14 years in the field of tick biology and vector-borne diseases. Beginning his career at the Nanchang Centre for Disease Control and Prevention, Zheng focused on the epidemiology and control of ticks and tick-borne diseases, publishing his findings on tick distribution and pathogen prevalence. He has made significant contributions to understanding tick populations in Hainan Province and surrounding areas, addressing public health concerns in regions prone to tick-borne diseases. In February 2023, Zheng joined Hainan Medical University as an Associate Professor, where he shifted focus to studying tick-microbe interactions and their influence on tick growth and development. His expertise includes the regulation of tick growth by Coxiella symbionts, a topic he is currently investigating in-depth. He is a key figure in tick-borne disease research in China and has contributed to international research on tick ecology, with notable publications in well-regarded journals.

Research Focus:

Dr. Zheng’s research focuses on the complex interactions between ticks and microbes, specifically investigating how symbiotic microbes, like Coxiella, influence tick biology, growth, and development. His work explores how microbial endosymbionts regulate tick reproduction, survival, and fitness, with particular emphasis on their role in tick-borne disease transmission. Zheng’s studies also delve into tick ecology, including the distribution and prevalence of ticks and tick-borne pathogens across various regions of China. His research aims to enhance the understanding of tick-microbe interactions, offering insights that could lead to more effective control and prevention strategies for tick-borne diseases. Zheng has contributed to the identification of novel microbial symbionts, and his ongoing research aims to uncover mechanisms by which these microbes affect tick physiology. His work has broad implications for public health, particularly in areas affected by tick-borne diseases such as Lyme disease and Severe Fever with Thrombocytopenia Syndrome.

Publications Top Notes:

  1. Severe fever with thrombocytopenia syndrome virus found in Northern Jiangxi Province, China 🦠

  2. Identification and Characterization of Rhipicephalus microplus ATAQ Homolog from Haemaphysalis longicornis Ticks and Its Immunogenic Potential as an Anti-Tick Vaccine Candidate Molecule 🐜🔬

  3. Coxiella R1 symbiont regulates the Asian long-horned tick on its reproduction and development 🦗

Conclusion:

Dr. Zheng’s achievements and contributions to tick biology, especially his exploration of tick-microbe interactions and the regulation of tick growth, make him a strong candidate for the Research for Excellence in Research Award. His research has significant implications for tick-borne disease prevention and control, which aligns with both scientific advancement and public health priorities. Given his strong publication record, citation impact, and the innovative nature of his work, Dr. Zheng is undoubtedly a deserving nominee for this prestigious award.

 

 

 

qingwei lu | Cell Differentiation Processes | Innovative Research Award

Published on by Cell Biologist

Mr. qingwei lu | Cell Differentiation Processes | Innovative Research Award

Mr. qingwei lu , Xinjiang Academy of Animal Sciences , China

Qingwei Lu is a student at the Xinjiang Academy of Animal Sciences, China, specializing in animal genetics, breeding, and reproduction. His research focuses on the genetic improvement of wool and meat sheep, specifically through quantitative genetics, population genetic analysis, and genomic selection for key traits. Qingwei also explores the molecular mechanisms behind hair follicle development in cashmere goats, applying transcriptomics and proteomics to understand hair follicle cycling and its relationship with production traits. His studies aim to provide scientific foundations for breeding and industrial development in the livestock sector. Qingwei is actively involved in national and international research collaborations and has published multiple academic papers in prominent journals. His work contributes significantly to the field of animal genetics and breeding, making him a promising researcher with a growing impact in the industry.

Publication Profile:

Orcid

Strengths for the Award:

Qingwei Lu’s work demonstrates remarkable innovation in the field of animal genetics, with a particular emphasis on sheep and cashmere goats. His integration of transcriptomics and proteomics techniques to study the genetic and molecular mechanisms of hair follicle development, especially in cashmere goats, is groundbreaking. The focus on secondary hair follicle cycling and the role of PLIN2 in regulating this cycle offers important insights for enhancing wool and meat production traits. Furthermore, his research is supported by substantial funding, such as the National Key R&D Program and the National Natural Science Foundation of China, underlining the relevance and impact of his work. His numerous published journal articles, including in high-impact journals, also reflect his contributions to advancing the scientific understanding of animal breeding and genetics.

Areas for Improvements:

While Qingwei Lu’s research is highly innovative and impactful, expanding his collaborative network further to include industry partners could enhance the translational aspect of his research. Additionally, more engagement with public-facing scientific communication and outreach could make his discoveries more accessible to a broader audience, including agricultural industries and farmers.

Education:

Qingwei Lu is currently pursuing advanced studies at the Xinjiang Academy of Animal Sciences in China. He holds a bachelor’s degree in animal science, followed by graduate studies focused on animal genetics and breeding. His academic journey is heavily centered on animal genetics, specifically in the context of wool and meat sheep, as well as the genetic improvement of cashmere goats. Qingwei’s research includes the application of quantitative genetics, genomic selection, and molecular techniques to unravel complex genetic traits in livestock. His education equips him with strong foundations in both the theoretical and practical aspects of animal breeding, enabling him to work effectively on high-impact national research projects. Qingwei’s academic achievements reflect his dedication to the scientific advancement of animal science, particularly in genetic evaluation and breeding program optimization.

Experience:

Qingwei Lu’s research experience spans multiple projects in the field of animal genetics and breeding. His primary research focuses on the genetic enhancement of sheep and goats, particularly wool and meat sheep, and cashmere goats, through innovative approaches in genomics and molecular biology. Qingwei’s work includes estimating genetic parameters, analyzing population genetic structures, and implementing genomic selection to improve economic traits in livestock. He is currently involved in key national research programs in China, including the National Key R&D Program (2021YFD1200902) and the National Natural Science Foundation of China Regional Science Fund (32360814). His collaborative research efforts have resulted in numerous journal publications. Qingwei also collaborates on industry-sponsored projects, contributing his expertise to practical breeding solutions for livestock farmers. His expertise in combining transcriptomics, proteomics, and genomic techniques is making a significant impact on livestock breeding and industrial development.

Research Focus:

Qingwei Lu’s research focus revolves around the genetic improvement of livestock, with particular emphasis on wool and meat sheep, and cashmere goats. His research involves the use of quantitative genetics to estimate genetic parameters, analyze population genetic structures, and implement genomic selection for important economic traits such as early growth and reproductive traits. Additionally, Qingwei studies the genetic and molecular mechanisms of hair follicle development in cashmere goats, aiming to uncover the regulatory pathways behind hair follicle cycling. His work integrates transcriptomics, proteomics, and genomic sequencing techniques to explore how these molecular processes influence the production of wool and cashmere. By understanding these molecular mechanisms, Qingwei seeks to develop breeding strategies that can enhance productivity and economic outcomes in the livestock industry. His work provides valuable insights for improving livestock breeding programs and contributes to the scientific foundation for the development of more sustainable and profitable animal farming.

Publications Top Notes:

  1. Screening of CircRNA Related to Secondary Hair Follicle Cycling in Southern Xinjiang Cashmere Goats
    🐐📚 Chinese Journal of Animal Husbandry and Veterinary Medicine, 2024 | DOI: 10.19556/j.0258-7033.20230117-04

  2. Effects of Non-genetic Factors on Early Growth Traits in Southern Xinjiang Cashmere Goats
    🐐📖 Chinese Journal of Animal Science, 2024 | DOI: 10.16431/j.cnki.1671-7236.2024.05.001

  3. Research on the Cyclical Patterns of Different Types of Hair Follicles in Southern Xinjiang Cashmere Goats
    🐐🔬 Chinese Journal of Animal Science, 2025 | DOI: 10.19556/j.0258-7033.20240422-10

  4. Comparison of Different Animal Models for Estimating Genetic Parameters for Early Growth Traits and Reproductive Traits in Tianmu Sainuo Sheep
    🐑📄 Frontiers in Veterinary Science, 2024 | DOI: 10.3389/fvets.2024

  5. Proteomics Reveals the Role of PLIN2 in Regulating the Secondary Hair Follicle Cycle in Cashmere Goats
    🧬🐐 International Journal of Molecular Sciences, 2025 | DOI: 10.3390/ijms26062710

Conclusion:

Qingwei Lu’s innovative approach to genetic improvement in sheep and goats, particularly his exploration of hair follicle regulation mechanisms and their relation to production traits, makes him an excellent candidate for the Innovative Research Award. His contributions to advancing genetic evaluation and breeding programs have the potential to greatly impact agricultural industries, aligning well with the goals of the award.

Alma Burlingame | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Prof. Alma Burlingame | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Alma Burlingame , UCSF , United States

Alma L. Burlingame is a distinguished Professor of Chemistry and Pharmaceutical Chemistry at the University of California, San Francisco. She has over five decades of experience in the fields of mass spectrometry, proteomics, and systems biology. With expertise in the identification and study of unknown proteins and post-translational modifications like phosphorylation, acetylation, and glycosylation, her work has contributed significantly to understanding protein dynamics. Dr. Burlingame has been a pioneer in proximity-biotin labeling for protein complex discovery and has earned widespread recognition for her interdisciplinary contributions to molecular biology and chemistry. Her long-standing collaboration with various international research institutions has fostered advancements in protein interaction and cellular signaling pathways, marking her as a leader in her field.

Publication Profile:

Scopus

Strengths for the Award:

  1. Innovative Contributions: Dr. Burlingame has made significant contributions to mass spectrometry, proteomics, and systems biology, especially in the development of new methodologies for protein analysis and post-translational modifications. Her work in identifying and studying unknown proteins and their modifications has broadened the scope of proteomics.

  2. Multidisciplinary Expertise: Her expertise spans across various fields including chemistry, physics, biological sciences, and medicine, demonstrating her versatility and depth of knowledge in complex scientific issues.

  3. Impact on the Scientific Community: Through her extensive publication record and influential research, Dr. Burlingame has advanced our understanding of protein dynamics, cell signaling, and the role of glycosylation and phosphorylation in health and disease.

  4. Leadership and Mentorship: Dr. Burlingame’s leadership roles, particularly as a co-chair of major international symposia, reflect her stature in the scientific community. Additionally, her mentorship of students and postdocs has helped shape the next generation of scientists in proteomics and systems biology.

Areas for Improvement:

  1. Broader Collaboration with Clinical Applications: While Dr. Burlingame’s research is foundational in proteomics, further expansion of collaborative work with clinical researchers could enhance the practical application of her discoveries, particularly in disease diagnosis and therapeutics.

  2. Public Outreach: Given the complexity of her research, efforts to communicate her findings to broader audiences could help bridge the gap between academic research and public understanding of the significance of proteomics in health.

Education:

Dr. Burlingame earned her Bachelor of Science degree from the University of Rhode Island in 1959. She went on to complete her PhD in Chemistry and Physics at the Massachusetts Institute of Technology (MIT) in 1962. She further honed her scientific expertise as a Guggenheim Fellow at the Karolinska Institute in Stockholm, Sweden, in 1972, specializing in Physiological Chemistry. Over the years, Dr. Burlingame has continued to advance her education, conducting cutting-edge research in the realms of mass spectrometry, proteomics, and the study of post-translational modifications. Her rigorous academic background, combined with her groundbreaking work, has made her a respected figure in biochemistry and molecular biology.

Experience:

Dr. Burlingame has held several prominent positions throughout her distinguished career. She currently serves as a Professor of Chemistry and Pharmaceutical Chemistry at the University of California, San Francisco. She has also held significant roles such as a University Fellow at Hong Kong Baptist University and Professor of Biochemistry at University College London. Dr. Burlingame has been recognized by the American Association for the Advancement of Science and has been an elected Fellow since 1990. Her professional journey includes visiting professorships at leading institutions such as the Ludwig Institute for Cancer Research. Additionally, she has co-chaired major international symposia on mass spectrometry, enhancing her reputation in the global scientific community. Her leadership and influence in research have made her a pivotal figure in mass spectrometry and proteomics.

Awards and Honors:

Dr. Burlingame has earned numerous prestigious honors throughout her career. In 2018, she was awarded the Albert Nelson Marquis Lifetime Achievement Award for her long-standing contributions to scientific research. She was named a Fellow of the American Society of Biochemistry and Molecular Biology in 2022. Her significant achievements were further recognized when she received the MCP Lectureship Plenary Award at the Society for Glycobiology in 2013. Additionally, she was honored with the Achievement Award from the International Forum of Proteomics in 2012 for her impactful work in proteomics. Her longstanding contributions to the field of mass spectrometry have made her an internationally respected leader, and she continues to inspire future generations of scientists.

Research Focus:

Dr. Burlingame’s research focuses on mass spectrometry, proteomics, and systems biology, with a specific emphasis on protein sequencing, identification, and the dynamics of post-translational modifications (PTMs). She has made significant contributions to understanding the site-specific dynamics of PTMs like phosphorylation, acetylation, and glycosylation, and their roles in cell signaling and differentiation. Her group is particularly known for its work in proximity-biotin labeling, a technique used for protein complex discovery and interactomics. She has also studied the dynamic nature of proteins involved in cellular processes such as protein synthesis, cell signaling, and differentiation. By studying how PTMs influence cellular functions, Dr. Burlingame’s work helps to uncover mechanisms underlying diseases like cancer and neurological disorders. Her innovative approaches in mass spectrometry and proteomics continue to influence the understanding of complex biological systems.

Publications Top Notes:

  1. Revealing nascent proteomics in signaling pathways and cell differentiation 🧬🔬

  2. Locally translated mTOR controls axonal local translation in nerve injury 🧠💥

  3. Mapping axon initial segment structure and function by multiplexed proximity biotinylation 🧬⚡

  4. Capture, release, and identification of newly synthesized proteins for improved profiling of functional translatomes 🔍🔬

  5. Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma 💉🧠

  6. Functional screen identifies RBM42 as a mediator of oncogenic mRNA translation specificity 🧬🔍

  7. Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation 🔑🧬

  8. TRIM46 Is Required for Microtubule Fasciculation In Vivo But Not Axon Specification or Axon Initial Segment Formation 🧠⚙️

  9. RAPIDASH: Tag-free enrichment of ribosome-associated proteins reveals composition dynamics in embryonic tissue, cancer cells, and macrophages 🧬📊

  10. Remodelling of the translatome controls diet and its impact on tumorigenesis 🥗🎯

Conclusion:

Dr. Alma Burlingame is undoubtedly a leading figure in the fields of mass spectrometry and proteomics. Her innovative research, mentorship, and contributions to the understanding of protein modifications and their implications for health make her a highly deserving candidate for the Best Researcher Award. Her work has had a profound and lasting impact on molecular biology, and she continues to be a driving force in scientific discovery.